Shelf-life studies use controlled storage, scheduled pull points, and repeated analytical or performance measurements to track changes in products, devices, formulations, packages, and materials over time. Programs can align with ICH Q1A (R2), FDA shelf-life guidance, and ISO 17025 requirements for condition control, sample identity, method QC, and traceable trend interpretation:
- ICH Q1A (R2) real-time programs for inhalation products using chamber storage, scheduled pulls, and PSD or emitted-dose trending.
- FDA shelf-life guidance support for nasal sprays or consumer aerosols using leakage, corrosion, valve behavior, and appearance checks.
- ASTM F1980 accelerated-aging bridges for medical devices or packages when real-time shelf-life evidence is still maturing.
- USP <1118> distribution-risk programs for packaged products using excursion logs, pull records, and post-storage performance retesting.
- ISO 17025 change-control comparisons for valves, actuators, packages, or formulations using matched lots and shared pull schedules.
Shelf-life studies are appropriate when a decision depends on product performance over time in storage, not a single release result. Before samples enter storage, the study plan defines the conditions, pull schedule, test attributes, acceptance criteria, and approach to trend analysis.